TSHZ1 and infection: The attack rate (AR) based on CAA positivity after the third exposure in the reinfection group was 82% (9 of 11) and 92% (11 of 12) in the infection control group, corresponding to a protective efficacy of 11% with a wide 95% CI that included zero (–24% to 35%), indicating no protection (P = 0.5).